and Hikma and partner Vectura require a further trial to get their drug past the FDA. A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Riad Mishlawi, Hikma’s CEO, said: “I am pleased ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms. Israel-based Teva said the ...

Dividend amount and dividend per share are quoted in the currency of the stock selected. Please note that past performance is not a reliable indicator of future returns. Important Information Please ...

Extended Release Tablets in the US" -Glenmark Pharma gets US FDA nod for Salmecort MDI Inhaler in Russia -The Cabinet Committee on Economic Affairs (CCEA) headed by PM has approved the foreign ...

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.